BAMF
PTCT icon

BI Asset Management Fondsmaeglerselskab’s PTC Therapeutics PTCT Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-81,878
Closed -$5.58M – 731
2026
Q1 		$5.58M Sell
81,878
-77,599
-49% -$5.5M 0.06% 239
2025
Q4 		$12.1M Buy
159,477
+64,472
+68% +$4.69M 0.11% 153
2025
Q3 		$5.83M Sell
95,005
-31,115
-25% -$1.62M 0.05% 239
2025
Q2 		$6.16M Buy
126,120
+124,925
+10,454% +$5.93M 0.06% 221
2025
Q1 		$61K Buy
+1,195
New +$59.6K ﹤0.01% 760
2019
Q4 		– Sell
-583
Closed -$20K – 412
2019
Q3 		$20K Buy
+583
New +$25.4K ﹤0.01% 357

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's PTCT Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab sold out of PTC Therapeutics (PTCT) in Q2 2026, closing a stake of 81,878 shares — an estimated $5.58M sold.

BI Asset Management Fondsmaeglerselskab first reported a position in PTCT in Q3 2019 and held it in 6 quarters. The position peaked at $12.1M in Q4 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • BI Asset Management Fondsmaeglerselskab reported no remaining PTC Therapeutics position as of Q2 2026 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 81,878 PTC Therapeutics shares in Q2 2026, an estimated $5.58M.
  • BI Asset Management Fondsmaeglerselskab first reported a position in PTC Therapeutics in Q3 2019 and held it in 6 quarters.
  • BI Asset Management Fondsmaeglerselskab's PTC Therapeutics position peaked at $12.1M in Q4 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.